Butterfly Network (BFLY) Cash from Investing Activities (2020 - 2026)

Butterfly Network (BFLY) reported Cash from Investing Activities of -$950000.0 for Q1 2026, down 169.12% on a YoY basis from $1.4 million in Q1 2025, and up 12.28% sequentially from -$1.1 million in Q4 2025.

Butterfly Network (BFLY) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Butterfly Network (BFLY) has 7 years of Cash from Investing Activities data on file, last reported at -$950000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 169.12% year-over-year to -$950000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.9 million (down 110.62% YoY), and the FY2025 full-year result was -$3.3 million, down 25.96% from the prior year.
  • Cash from Investing Activities advanced to -$950000.0 in Q1 2026, from -$1.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $74.9 million in Q1 2023 to a low of -$79.7 million in Q3 2022.
  • A 5-year average of -$1.8 million and a median of -$1.0 million in 2025 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities surged 1761.23% in 2023 and sank 169.12% in 2026, its largest moves.
  • Tracing BFLY's Cash from Investing Activities over 5 years: stood at -$2.5 million in 2022, then retreated by 1.25% to -$2.5 million in 2023, then surged by 83.76% to -$408000.0 in 2024, then plunged by 165.44% to -$1.1 million in 2025, then grew by 12.28% to -$950000.0 in 2026.
  • Business Quant data shows BFLY's Cash from Investing Activities at -$950000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Butterfly Network 1.79 Bn 1.65 Bn 18.29 Mn -950,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -950,000.00
Mar 31, 2026 -950,000.00
Dec 31, 2025 -1.08 Mn
Dec 31, 2025 -1.08 Mn
Sep 30, 2025 -1.02 Mn
Sep 30, 2025 -1.02 Mn
Jun 30, 2025 -896,000.00
Jun 30, 2025 -896,000.00
Mar 31, 2025 -353,000.00
Mar 31, 2025 -353,000.00
Dec 31, 2024 -408,000.00
Dec 31, 2024 -408,000.00
Sep 30, 2024 -413,000.00
Sep 30, 2024 -413,000.00
Jun 30, 2024 -699,000.00
Jun 30, 2024 -699,000.00
Mar 31, 2024 -1.14 Mn
Mar 31, 2024 -1.14 Mn
Dec 31, 2023 -2.51 Mn
Dec 31, 2023 -2.51 Mn